| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Artivion, Inc. (AORT) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. AORT is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 831.9K | $16.74M | - | |
| Other | 193.8K | $3.90M | - | |
| VP | 156.1K | $3.14M | - | |
| VP | 130.1K | $2.62M | - | |
| VP | 71.8K | $1.45M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 15, 2024 | Green Andrew M | VP Regulatory | Sell | 1,462 | $20.00 | $29,240.00 | -3.4% | +18.0% | +22.1% | |
| Mar 14, 2024 | Green Andrew M | VP Regulatory | Sell | 3,994 | $20.00 | $79,880.00 | -8.6% | +17.4% | +20.1% | |
| Mar 12, 2024 | Getz Matthew A | VP, Human Resources | Sell | 5,000 | $19.94 | $99,719.50 | -10.3% | +16.4% | +17.5% | |
| Mar 5, 2024 | Maney Rochelle L. | VP, Quality | Sell | 1,157 | $18.72 | $21,661.82 | -2.4% | +26.6% | +36.5% | |
| Mar 5, 2024 | MacKin James P53 | President &CEO | Sell | 13,996 | $18.72 | $262,037.31 | -1.9% | +26.6% | +36.5% | |
| Mar 5, 2024 | Holloway Jean F49 | SVP, General Counsel | Sell | 2,380 | $18.72 | $44,558.84 | -1.4% | +26.6% | +36.5% | |
| Mar 5, 2024 | Davis John E | Chief Commercial Officer | Sell | 2,022 | $18.72 | $37,856.29 | -1.2% | +26.6% | +36.5% | |
| Mar 5, 2024 | Getz Matthew A | VP, Human Resources | Sell | 1,157 | $18.72 | $21,661.35 | -2.3% | +26.6% | +36.5% | |
| Mar 5, 2024 | Green Andrew M | VP Regulatory | Sell | 1,160 | $18.72 | $21,717.64 | -2.4% | +26.6% | +36.5% | |
| Mar 5, 2024 | Stanton Marshall S. | SVP, Clinical &MD Affair | Sell | 1,506 | $18.72 | $28,195.48 | -1.7% | +26.6% | +36.5% |